Mylotarg and condition aggravated 
Mylotarg and condition aggravated Patient Reports February 12, 2012
Mylotarg Side Effects Report #4928531-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2006. Male patient, 57 years of age, weighting 204.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, blood bilirubin increased, blood sodium decreased, chromaturia, condition aggravated, discomfort, eating disorder , epistaxis. Mylotarg dosage: 6 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ARSENIC TRIOXIDE, POTASSIUM CHLORIDE, PREVACID, COMPAZINE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4957371-7
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Mar 14, 2006. Male patient, 57 years of age, weighting 204.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, blood bilirubin increased, blood sodium decreased, chromaturia, condition aggravated, discomfort, disease progression, epistaxis. Mylotarg dosage: 6 MG 1X PER 1 DAY; INTRAVENOUS. During the same period patient was treated with ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, POTASSIUM CHLORIDE, PREVACID, COMPAZINE. Patient was hospitalized. Patient died on 03/10/2006.Mylotarg Side Effects Report #4969531-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 24, 2006. Male patient, 57 years of age, weighting 204.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, blood bilirubin increased, blood sodium decreased, chromaturia, condition aggravated, discomfort, disease progression, epistaxis. Mylotarg dosage: 6 MG 1X PER 1 DAY; INTRAVENOUS. During the same period patient was treated with ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, POTASSIUM CHLORIDE, PREVACID, COMPAZINE. Patient was hospitalized. Patient died on 03/10/2006.Mylotarg Side Effects Report #5131612-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 05, 2006. Female patient, 78 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, febrile neutropenia, pneumonia
, sepsis . Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY; INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, URSO, OMEPRAZOLE, SULFAMETHOXAZOLE, DIFLUCAN, STRONG NEO MINOPHAGEN C. Patient died.Mylotarg Side Effects Report #4937095-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 17, 2006. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bone marrow failure, condition aggravated, febrile neutropenia. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with MODACIN, SULPERAZON, TIENAM, CIPROFLOXACIN HYDROCHLORIDE, MEROPEN, PRODIF, POLYMYXIN B SULPHATE. Patient recovered.
Mylotarg Side Effects Report #5158527-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 07, 2006. Female patient, 73 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, condition aggravated, disease progression, disseminated intravascular coagulation, febrile neutropenia, hyperuricaemia, hypokalaemia, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with LIVALO, ENALAPRIL MALEATE, ADALAT OR, METHYCOBAL, ASPARA K, MUCOSOLVAN, LEVOFLOXACIN. Patient recovered.
Mylotarg Side Effects Report #5105263-5
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Aug 29, 2006. Male patient, 70 years of age, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, condition aggravated, dyspnoea, infusion related reaction, international normalised ratio increased, pyrexia, thrombocytopenia. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4977021-3
Mylotarg side effect was reported by a Physician from UNITED STATES on Mar 30, 2006. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, condition aggravated, dyspnoea, infusion related reaction, international normalised ratio increased, pyrexia. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, TYLENOL, ZOSYN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5080806-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on July 28, 2006. Male patient, 69 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, condition aggravated, disease progression, gastrointestinal haemorrhage, hypocalcaemia, neutrophil count decreased, oral intake reduced, platelet count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with AMLODIPINE BESYLATE, LONGES, MUCOSTA, CHLORMADINONE ACETATE, HUMALOG, NOVOLIN N. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #5158495-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 09, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bone marrow failure, condition aggravated, hypotension, liver disorder, pulmonary haemorrhage, renal failure, rhabdomyolysis, sepsis
, tumour lysis syndrome. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE. During the same period patient was treated with AMIKACIN SULPHATE, AMIKACIN SULPHATE, MEROPEN, MODACIN, FRAGMIN, VFEND. Patient died.Mylotarg Side Effects Report #4974424-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 28, 2006. Male patient, 69 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, condition aggravated, hypocalcaemia, neutrophil count decreased, platelet count decreased, pyrexia, unevaluable event. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with AMLODIPINE BESYLATE, LISINOPRIL, MUCOSTA, CHLORMADINONE ACETATE, HUMALOG, NOVOLIN N. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5032003-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 06, 2006. Male patient, 69 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, haemorrhage, hypocalcaemia, neutrophil count decreased, oral intake reduced, platelet count decreased, pyrexia. Mylotarg dosage: 9 MG/M^2 PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with AMLODIPINE BESYLATE, LONGES, MUCOSTA, CHLORMADINONE ACETATE, HUMALOG, NOVOLIN N. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4972939-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 29, 2006. Male patient, 57 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: c-reactive protein increased, condition aggravated, disseminated intravascular coagulation, epistaxis, gastrointestinal haemorrhage, hyperchloraemia, hypernatraemia, hypokalaemia, malignant neoplasm progression. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with DIFLUCAN, RABEPRAZOLE, BEZATOL, EVAMYL, CARBENIN. Patient recovered.
Mylotarg Side Effects Report #5053133-3
Mylotarg side effect was reported by a Health Professional from JAPAN on June 29, 2006. Female patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blast cell count increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, coagulation factor xiii level decreased, condition aggravated, disease progression, febrile neutropenia. Mylotarg dosage: A SINGLE 7 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with ROXATIDINE ACETATE, ZOFRAN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5019634-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 22, 2006. Female patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blast cell count increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, coagulation factor xiii level decreased, condition aggravated, disease progression, febrile neutropenia. Mylotarg dosage: A SINGLE 7 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with ROXATIDINE ACETATE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4958838-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 14, 2006. Male patient, 52 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaphylactic reaction, cardiac failure congestive, chills, condition aggravated, disease progression, neutrophil percentage decreased, pneumonia
, pyrexia, white blood cell count decreased. Mylotarg dosage: A SINGLE 5 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with BICARBONATE, HABEKACIN, LAMIVUDINE, FAMOTIDINE, MUCOSTA, SULFAMETHOXAZOLE, POLYMYXIN, FUNGIZONE. Patient died.Mylotarg Side Effects Report #5023801-8
Mylotarg side effect was reported by a Health Professional from JAPAN on May 23, 2006. Male patient, 52 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, disease progression, infusion related reaction, neutrophil percentage decreased, pneumonia
, white blood cell count decreased. Mylotarg dosage: A SINGLE 5 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with BICARBONATE, HABEKACIN, LAMIVUDINE, FAMOTIDINE, MUCOSTA, SULFAMETHOXAZOLE, POLYMYXIN, FUNGIZONE. Patient died.Mylotarg Side Effects Report #5202094-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 25, 2006. Female patient, 29 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, bronchopulmonary aspergillosis, condition aggravated, haematocrit decreased, haemoglobin decreased, herpes zoster, immunosuppression, platelet count decreased, pleural effusion. Mylotarg dosage: 9 MG/M^2 1 X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with ETOPOSIDE, VFEND, CEFTAZIDIME, AMIKACIN SULPHATE, MEROPEN, TARGOCID, SULFAMETHOXAZOLE. Patient recovered.
Mylotarg Side Effects Report #5223667-7
Mylotarg side effect was reported by a Physician from JAPAN on Jan 18, 2007. Male patient, weighting 130.1 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, cellulitis
, condition aggravated, diarrhoea, epistaxis, hepatic function abnormal, neutrophil count decreased, platelet count decreased, sepsis . Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE, KYTRIL, SAXIZON, NOVANTRONE, ITRACONAZOLE, FAMOTIDINE. Patient was hospitalized. Patient died on 09/02/2006.Mylotarg Side Effects Report #5238060-0
Mylotarg side effect was reported by a Physician from JAPAN on Feb 06, 2007. Male patient, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, cystitis haemorrhagic, platelet count decreased, postrenal failure, retinal haemorrhage, sepsis
. Mylotarg dosage: unknown. During the same period patient was treated with AMLODIPINE BESYLATE, GASTER, BAKTAR, PREDONINE, LASIX. Patient died on 06/27/2006.Mylotarg Side Effects Report #5238583-4
Mylotarg side effect was reported by a Physician from JAPAN on Feb 06, 2007. Male patient, weighting 138.9 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, neutropenia, perianal abscess, platelet count decreased, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with KEITEN, FUNGUARD, MEROPEN, ZOVIRAX, FUNGIZONE, VANCOMYCIN HYDROCHLORIDE, TARGOCID. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5255383-X
Mylotarg side effect was reported by a Physician from JAPAN on Feb 21, 2007. Male patient, weighting 119.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, hypoxia, infection
, interstitial lung disease, tumour lysis syndrome. Mylotarg dosage: unknown. During the same period patient was treated with FIRSTCIN, DIOVAN, AMARYL, MELBIN, ORGARAN, FUNGUARD. Patient died on 06/23/2006.Mylotarg Side Effects Report #5257030-X
Mylotarg side effect was reported by a Physician from JAPAN on Feb 23, 2007. Male patient, weighting 130.1 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, cellulitis
, condition aggravated, diarrhoea, epistaxis, hepatic function abnormal, mucous membrane disorder, neutrophil count decreased, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE, KYTRIL, SAXIZON, NOVANTRONE, ITRACONAZOLE, FAMOTIDINE. Patient was hospitalized. Patient died on 09/02/2006.Mylotarg Side Effects Report #5257031-1
Mylotarg side effect was reported by a Physician from JAPAN on Feb 24, 2007. Male patient, weighting 90.39 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, fibrin degradation products increased, lung infection, obliterative bronchiolitis, sepsis
. Mylotarg dosage: unknown. During the same period patient was treated with MAXIPIME, FIRSTCIN, CIPROFLOXACIN, NORMAL IMMUNOGLOBULIN, TARGOCID, FUNGUARD, PREDONINE. Patient was hospitalized. Patient died on 01/31/2007.Mylotarg Side Effects Report #5259036-3
Mylotarg side effect was reported by a Physician from JAPAN on Mar 02, 2007. Female patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, herpes zoster, malaise, platelet count decreased, pleural effusion, pneumonia
, pyrexia. Mylotarg dosage: unknown. During the same period patient was treated with VFEND, MODACIN, MEROPENEM, TARGOCID, BAKTAR, POLYMYXIN B SULPHATE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5259683-9
Mylotarg side effect was reported by a Physician from JAPAN on Feb 27, 2007. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, condition aggravated, pharyngitis, platelet count decreased, pneumonia
, sepsis , septic shock, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE, FUNGUARD, CYTARABINE, ITRACONAZOLE, OMEGACIN, BAKTAR, METHOTREXATE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5272838-2
Mylotarg side effect was reported by a Physician from JAPAN on Mar 20, 2007. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, condition aggravated, pharyngitis, platelet count decreased, pneumonia
, sepsis , septic shock. Mylotarg dosage: unknown. During the same period patient was treated with VANCOMYCIN, FUNGUARD, CYLOCIDE, ITRACONAZOLE, OMEGACIN, BAKTAR, METHOTREXATE. Patient was hospitalized and became disabled. Patient recovered.Mylotarg Side Effects Report #5280338-9
Mylotarg side effect was reported by a Physician from JAPAN on Mar 20, 2007. Female patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: chills, condition aggravated, disseminated intravascular coagulation, hypoxia, neutrophil count decreased, pyrexia. Mylotarg dosage: unknown. During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, MEROPEN, OMEGACIN. Patient recovered.
Mylotarg Side Effects Report #5281844-3
Mylotarg side effect was reported by a Physician from JAPAN on Mar 23, 2007. Male patient, weighting 138.9 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, neutropenia, perianal abscess, platelet count decreased, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with KEITEN, FUNGUARD, MEROPEN, ZOVIRAX, FUNGIZONE, VANCOMYCIN, TARGOCID. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5283739-8
Mylotarg side effect was reported by a Physician from JAPAN on Mar 23, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, emphysema and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, anaemia, c-reactive protein increased, condition aggravated, disseminated intravascular coagulation, febrile neutropenia, peptic ulcer
, thrombocytopenia. Mylotarg dosage: unknown. During the same period patient was treated with MUCOSTA, BAKTAR, POLYMYXIN B SULPHATE, CLARITHROMYCIN, ZANTAC, DIFLUCAN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5299276-0
Mylotarg side effect was reported by a Physician from JAPAN on Apr 12, 2007. Male patient, weighting 130.1 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, cellulitis
, condition aggravated, diarrhoea, epistaxis, hepatic function abnormal, mucous membrane disorder, neutrophil count decreased. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE, KYTRIL, SAXIZON, NOVANTRONE, ITRACONAZOLE, FAMOTIDINE. Patient was hospitalized. Patient died on 09/02/2006.Mylotarg Side Effects Report #5300796-0
Mylotarg side effect was reported by a Physician from JAPAN on Apr 12, 2007. Female patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, herpes zoster, malaise, platelet count decreased, pleural effusion, pneumonia
, pyrexia. Mylotarg dosage: unknown. During the same period patient was treated with VFEND, MODACIN, MEROPENEM, TARGOCID, BAKTAR, POLYMYXIN B SULPHATE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5316591-2
Mylotarg side effect was reported by a Physician from JAPAN on Apr 27, 2007. Male patient, weighting 90.39 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, fibrin degradation products increased, lung infection, obliterative bronchiolitis, sepsis
. Mylotarg dosage: unknown. During the same period patient was treated with MAXIPIME, FIRSTCIN, CIPROFLOXACIN, NORMAL IMMUNOGLOBULIN, TARGOCID, FUNGUARD, PREDONINE. Patient was hospitalized. Patient died on 01/31/2007.Mylotarg Side Effects Report #5324992-1
Mylotarg side effect was reported by a Physician from JAPAN on May 07, 2007. Male patient, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, condition aggravated, haematuria, hypokalaemia, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with ITRACONAZOLE, MAXIPIME, IDAMYCIN, NOVANTRONE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5353493-X
Mylotarg side effect was reported by a Physician from JAPAN on May 31, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, emphysema and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, anaemia, blast cell count increased, blood potassium increased, c-reactive protein increased, condition aggravated, disseminated intravascular coagulation, febrile neutropenia. Mylotarg dosage: unknown. During the same period patient was treated with MUCOSTA, BAKTAR, POLYMYXIN B SULPHATE, CLARITHROMYCIN, ZANTAC, DIFLUCAN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5372365-8
Mylotarg side effect was reported by a Physician from JAPAN on June 20, 2007. Male patient, weighting 90.39 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, fibrin degradation products increased, lung infection, neutropenia, obliterative bronchiolitis, sepsis
. Mylotarg dosage: unknown. During the same period patient was treated with MAXIPIME, FIRSTCIN, CIPROFLOXACIN, NORMAL IMMUNOGLOBULIN, TARGOCID, FUNGUARD, PREDONINE. Patient was hospitalized. Patient died on 01/31/2007.Mylotarg Side Effects Report #5382828-7
Mylotarg side effect was reported by a Physician from JAPAN on July 02, 2007. Male patient, weighting 130.1 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, cellulitis
, condition aggravated, diarrhoea, epistaxis, hepatic function abnormal, mucous membrane disorder, neutrophil count decreased. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE, KYTRIL, SAXIZON, NOVANTRONE, ITRACONAZOLE, FAMOTIDINE. Patient was hospitalized. Patient died on 09/02/2006.Mylotarg Side Effects Report #5386496-X
Mylotarg side effect was reported by a Physician from JAPAN on July 05, 2007. Male patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, epilepsy
, neutrophil count decreased, tonsillitis. Mylotarg dosage: unknown. During the same period patient was treated with DIFLUCAN, ALEVIATIN, BAKTAR, MUCOSTA, LANSOPRAZOLE, HARNAL. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5395434-5
Mylotarg side effect was reported by a Physician from JAPAN on July 17, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, liver disorder, neutropenia, platelet count decreased, pneumocystis jiroveci pneumonia. Mylotarg dosage: unknown. During the same period patient was treated with PREDONINE, SELBEX. Patient died on 06/24/2007.
Mylotarg Side Effects Report #5404331-8
Mylotarg side effect was reported by a Physician from JAPAN on July 26, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, anaemia, blast cell count increased, blood potassium increased, c-reactive protein increased, condition aggravated, disseminated intravascular coagulation, febrile neutropenia. Mylotarg dosage: unknown. During the same period patient was treated with BAKTAR, DIFLUCAN, POLYMYXIN B SULPHATE, ZANTAC, MUCOSTA. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5451549-4
Mylotarg side effect was reported by a Physician from JAPAN on Sept 04, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, hypoproteinaemia, liver disorder, neutropenia, platelet count decreased, pneumocystis jiroveci pneumonia. Mylotarg dosage: unknown. During the same period patient was treated with PREDONINE, DIFLUCAN, SELBEX. Patient was hospitalized. Patient died on 06/24/2007.
Mylotarg Side Effects Report #5475404-9
Mylotarg side effect was reported by a Physician from JAPAN on Sept 26, 2007. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood fibrinogen decreased, condition aggravated, disseminated intravascular coagulation, fibrin degradation products increased, hypokalaemia, platelet count decreased, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with RENIVACE, ADALAT, METHYCOBAL, POTASSIUM CHLORIDE, MUCOSOLVAN, LEVOFLOXACIN, DIFLUCAN. Patient recovered.
Mylotarg Side Effects Report #5481191-0
Mylotarg side effect was reported by a Physician from JAPAN on Sept 28, 2007. Male patient, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood lactate dehydrogenase increased, blood uric acid decreased, c-reactive protein increased, condition aggravated, febrile neutropenia, gastrointestinal haemorrhage, haematemesis. Mylotarg dosage: unknown. During the same period patient was treated with ITRIZOLE, MAXIPIME, IDAMYCIN, NOVANTRONE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5485215-6
Mylotarg side effect was reported by a Physician from JAPAN on Oct 04, 2007. Male patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, epilepsy
, neutrophil count decreased, tonsillitis. Mylotarg dosage: unknown. During the same period patient was treated with DIFLUCAN, PHENYTOIN CAP, BAKTAR, MUCOSTA, LANSOPRAZOLE, HARNAL. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5524941-7
Mylotarg side effect was reported by a Physician from UNITED STATES on Nov 17, 2007. Male patient, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, c-reactive protein increased, condition aggravated, febrile neutropenia, haematemesis, haematuria, hypokalaemia, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with ITRIZOLE, MAXIPIME, IDAMYCIN, NOVANTRONE. Patient was hospitalized. Patient died on 05/01/2007.
Mylotarg Side Effects Report #5564694-X
Mylotarg side effect was reported by a Physician from JAPAN on Dec 13, 2007. Male patient, weighting 145.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, neutrophil count decreased and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, glucose tolerance impaired, haemolytic anaemia, hypokalaemia, left ventricular dysfunction, platelet count decreased, staphylococcal sepsis, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with FUNGUARD, CARBENIN, AMBISOME, CRAVIT, BAKTAR. Patient recovered.
Mylotarg Side Effects Report #5565269-9
Mylotarg side effect was reported by a Physician from JAPAN on Dec 07, 2007. Male patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, epilepsy
, neutrophil count decreased, platelet count decreased, tonsillitis. Mylotarg dosage: unknown. During the same period patient was treated with DIFLUCAN, PHENYTOIN CAP, BAKTAR, MUCOSTA, TAKEPRON, HARNAL. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5570385-1
Mylotarg side effect was reported by a Physician from JAPAN on Dec 18, 2007. Female patient was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, coagulopathy and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, febrile neutropenia, fungaemia, septic shock. Mylotarg dosage: unknown. During the same period patient was treated with FUNGUARD, KYTRIL, ORGARAN, CYANOCOBALAMIN, MUCOSTA. Patient died on 12/11/2006.
Mylotarg Side Effects Report #5574573-X
Mylotarg side effect was reported by a Physician from JAPAN on Dec 19, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, pneumonia
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, hypoproteinaemia, liver disorder, neutropenia, platelet count decreased, pneumocystis jiroveci pneumonia. Mylotarg dosage: unknown. During the same period patient was treated with PREDONINE, MICAFUNGIN, MIRACLID, CEFEPIME, VANCOMYCIN. Patient was hospitalized. Patient died on 06/24/2007.Mylotarg Side Effects Report #5601602-7
Mylotarg side effect was reported by a Physician from JAPAN on Jan 15, 2008. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disseminated intravascular coagulation, hypokalaemia, platelet count decreased, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, ADALAT, CYANOCOBALAMIN, POTASSIUM CHLORIDE, MUCOSOLVAN, CRAVIT, DIFLUCAN. Patient recovered.
Mylotarg Side Effects Report #5840386-4
Mylotarg side effect was reported by a Physician from JAPAN on July 31, 2008. Female patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal haemorrhage, hepatic function abnormal, pancytopenia, sepsis
. Mylotarg dosage: unknown. During the same period patient was treated with SOLANAX, MARZULENE, VINCRISTINE SULPHATE, CYTARABINE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5962958-9
Mylotarg side effect was reported by a Physician from JAPAN on Nov 13, 2008. Male patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, condition aggravated, graft versus host disease, neutrophil count decreased, obliterative bronchiolitis, pseudomonas infection, sepsis
. Mylotarg dosage: unknown. During the same period patient was treated with COTRIM, OMEPRAL, PROGRAF, UNIPHYL, BEZATOL, PREDONINE. Patient was hospitalized. Patient died on 05/08/2007.Mylotarg Side Effects Report #6104530-6
Mylotarg side effect was reported by a Physician from JAPAN on Feb 24, 2009. Male patient, weighting 145.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, neutrophil count decreased and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, glucose tolerance impaired, haemolytic anaemia, hypokalaemia, left ventricular dysfunction, platelet count decreased, staphylococcal sepsis, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with FUNGUARD, CARBENIN, AMBISOME, CRAVIT, BAKTAR. Patient recovered.
Mylotarg Side Effects Report #4867657-2
Mylotarg side effect was reported by a Physician from UNITED STATES on Apr 28, 1999. Male patient, 82 years of age, weighting 194.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: agitation, chills, condition aggravated, confusional state, fatigue, haematocrit decreased, haemorrhage intracranial, hypotension, leukopenia. Mylotarg dosage: 9 MG/M (2), INTRAVENOUS. During the same period patient was treated with CEFTAZIDIME, VANCOMYCIN, AZITHROMYCIN, PEPCID, FUROSEMIDE, NYSTATIN. Patient was hospitalized. Patient died on 02/17/1999.
Mylotarg Side Effects Report #5074408-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on July 26, 2006. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia, disease recurrence and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, condition aggravated, disease progression, febrile neutropenia, hypertension. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with CEFTAZIDIME, SULPERAZON, POLYMYXIN B SULPHATE, ULCERMIN, ALLOPURINOL, DIFLUCAN. Patient recovered.
Mylotarg Side Effects Report #5025982-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 30, 2006. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia, disease recurrence and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, bone marrow failure, condition aggravated, disease progression. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with CEFTAZIDIME, SULPERAZON, POLYMYXIN B SULPHATE, ULCERMIN. Patient recovered.
Mylotarg Side Effects Report #4952734-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2004. Male patient, 76 years of age, weighting 198.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acidosis, ascites, condition aggravated, dialysis
, enterococcal infection, hepatomegaly, hypotension, liver function test abnormal, renal failure. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with NPH INSULIN, MEROPENEM, MORPHINE SULPHATE, PHENERGAN, DARVON, URSODIOL, VANCOMYCIN. Patient was hospitalized. Patient died on 11/19/2003.Mylotarg Side Effects Report #4947093-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Female patient, 74 years of age, weighting 156.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: arrhythmia
, condition aggravated, disseminated intravascular coagulation, hypotension, infusion related reaction, respiratory distress, white blood cell count increased. Mylotarg dosage: 15 MG 1X PER 1 DAY; INTRAVENOUS. During the same period patient was treated with LASIX, PROTONIX, ALLOPURINOL, ACETAMINOPHEN, HALDOL SOLUTAB, ARICEPT, CELEXA, ZOSYN. Patient was hospitalized. Patient died on 03/03/2004.Mylotarg Side Effects Report #4843534-8
Mylotarg side effect was reported by a Pharmacist from UNITED STATES on Nov 16, 2005. Male patient, 71 years of age, weighting 155.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bone marrow failure, condition aggravated, epistaxis, gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, neutrophil count decreased, orthostatic hypotension, platelet count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with THEOPHYLLINE, IMDUR, ALLOPURINOL, CARAFATE, CEFEPIME, FLAGYL, VANCOMYCIN, IMMUNE GLOBULIN INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4976163-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 03, 2006. Male patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cerebral haemorrhage, condition aggravated, febrile neutropenia, glucose urine present, hepatic function abnormal. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, RANIMUSTINE, ADETPHOS. Patient died.
Mylotarg Side Effects Report #4616368-7
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 07, 2005. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, condition aggravated, dyspnoea, pyrexia, thrombocytopenia, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, TYLENOL, ZOSYN. Patient recovered.
Mylotarg Side Effects Report #4627225-4
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 18, 2005. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: apnoea, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, chills, condition aggravated, dyspnoea, hyperhidrosis. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, TYLENOL, ZOSYN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4631234-9
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 29, 2005. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, condition aggravated, dyspnoea, hyperhidrosis, international normalised ratio increased, pyrexia. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, AMBIEN, TYLENOL, ZOSYN, GENTAMICIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4949629-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, condition aggravated, dyspnoea, infusion related reaction, thrombocytopenia, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4693909-5
Mylotarg side effect was reported by a Consumer or non-health professional from on June 07, 2005. Female patient, 68 years of age, weighting 183.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: agitation, blood bilirubin increased, blood culture positive, cardiac arrest
, cellulitis , condition aggravated, culture urine positive, delirium, disorientation. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, GUAIFENESIN, MEGACE, CEFTAZIDIME, PROTONIX, ACYCLOVIR. Patient was hospitalized. Patient died on 05/14/2004.Mylotarg Side Effects Report #5097836-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2006. Female patient, 66 years of age, weighting 106.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, condition aggravated, culture urine positive, dyspnoea, enterococcal infection, haemoptysis, hydropneumothorax, leukaemia cutis, malignant neoplasm progression. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 12/03/2003.
Mylotarg Side Effects Report #4725798-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2005. Male patient, 65 years of age, weighting 198.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, abdominal pain lower, anorexia, condition aggravated, confusional state, enterocolitis, oral intake reduced. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE. Patient recovered.Mylotarg Side Effects Report #4735278-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2005. Male patient, 65 years of age, weighting 198.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain lower, anorexia, condition aggravated, confusional state, enterocolitis, oral intake reduced, platelet count decreased, pyrexia. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE. Patient died on 06/23/2005.
Mylotarg Side Effects Report #4804843-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 07, 2005. Female patient, 62 years of age, weighting 149.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, ejection fraction decreased. Mylotarg dosage: 16 MG 1X PER 1 DAY, INTRAVENOUS. Patient died on 07/18/2005.
Mylotarg Side Effects Report #4840173-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 10, 2005. Male patient, 62 years of age, weighting 183.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, bacterial infection
, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, hepatic enzyme increased, pneumonia fungal, pulmonary oedema. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS. During the same period patient was treated with LASIX, ETOPOSIDE, CYTOXAN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4948877-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 60 years of age, weighting 146.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, chills, condition aggravated, disease progression, fluid overload, hypotension, infusion related reaction, multi-organ failure, oxygen saturation decreased. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 10/24/2003.
Mylotarg Side Effects Report #4952360-0
Mylotarg side effect was reported by a Physician from UNITED STATES on Mar 08, 2006. Female patient, 59 years of age, weighting 335.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myocardial infarction, agitation, anaemia, aortic arteriosclerosis, arteriosclerosis coronary artery, blood albumin decreased, bradycardia, condition aggravated, depressed level of consciousness. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS; 8 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with AMBIEN, SYNTHROID, LEVAQUIN, HYDROCHLOROTHIAZIDE, ALLOPURINOL, MITOXANTRONE. Patient died on 02/06/2003.
Mylotarg Side Effects Report #5217084-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 09, 2007. Male patient, 58 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, condition aggravated, pharyngitis, platelet count decreased, pneumonia
, septic shock, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with MAXIPIME, VANCOMYCIN, FUNGUARD, TIENAM, ITRACONAZOLE, OMEGACIN, SULFAMETHOXAZOLE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5113466-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 08, 2006. Male patient, 58 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood lactate dehydrogenase increased, cardiac failure congestive, condition aggravated, haemoglobin decreased, interstitial lung disease, malignant neoplasm progression, performance status decreased, red blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with ITRACONAZOLE, CIPROXAN, ALLOPURINOL, DIOVAN, LANSOPRAZOLE, SELBEX, MAGNESIUM OXIDE, DEXTROMETHORPHAN HYDROBROMIDE. Patient recovered.
Mylotarg Side Effects Report #5023602-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 25, 2006. Female patient, 55 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, condition aggravated, disease progression, disseminated intravascular coagulation, pyrexia, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with CARBENIN, MAXIPIME, AMIKACIN SULPHATE, PRODIF, ANTITHROMBIN III, FRAGMIN. Patient recovered.
Mylotarg Side Effects Report #5084007-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 02, 2006. Female patient, 54 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaphylactic shock, condition aggravated, disseminated intravascular coagulation, renal failure. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with MAXIPIME, MINOCYCLINE HYDROCHLORIDE, FUTHAN. Patient recovered.
Mylotarg Side Effects Report #5105260-X
Mylotarg side effect was reported by a Physician from UNITED STATES on Aug 28, 2006. Male patient, 53 years of age, weighting 103.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, gallbladder disorder, weight increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. Patient recovered.
Mylotarg Side Effects Report #4975862-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 03, 2006. Male patient, 53 years of age, weighting 103.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, liver function test abnormal, weight increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. Patient recovered.
Mylotarg Side Effects Report #4653739-7
Mylotarg side effect was reported by a Consumer or non-health professional from on Apr 22, 2005. Male patient, 51 years of age, weighting 195.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood culture positive, condition aggravated, febrile neutropenia, renal failure acute. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with ABELCET, SPORANOX, REMERON, ACYCLOVIR, VITAMINS, VICODIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5032225-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2006. Male patient, 51 years of age, weighting 195.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, febrile neutropenia, liver function test abnormal, renal failure acute. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with ABELCET, SPORANOX, REMERON, ACYCLOVIR, VITAMINS, VICODIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4752901-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 11, 2005. Male patient, 50 years of age, weighting 242.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, chills, condition aggravated, confusional state, hyperhidrosis, hypotension, hypothermia
. Mylotarg dosage: 20 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, HYDROXYUREA, ALLOPURINLL, FLAGYL, CEFEPIME, BECLOMETHASONE DIPROPIONATE, LORATADINE, METOPROL. Patient recovered.Mylotarg Side Effects Report #5245425-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2007. Female patient, 48 years of age, was diagnosed with acute myeloid leukaemia, prophylaxis, depression
, pain and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cholelithiasis, condition aggravated, dizziness , fatigue, platelet aggregation, platelet count decreased, transient ischaemic attack. Mylotarg dosage: unknown. During the same period patient was treated with PREVACID, PAXIL, OXYCONTIN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5194151-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 20, 2006. Female patient, 48 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cholelithiasis, condition aggravated, dizziness
, fatigue, platelet aggregation, platelet count decreased, spleen disorder, transient ischaemic attack. Mylotarg dosage: unknown. During the same period patient was treated with OXYCONTIN, PREVACID, PAXIL. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5294994-2
Mylotarg side effect was reported by a Physician from UNITED STATES on Apr 05, 2007. Female patient, 38 years of age, weighting 158.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: arthralgia, back pain
, blood creatinine increased, blood glucose increased, condition aggravated, disease progression, hyperuricaemia, neutrophil count decreased, platelet count decreased. Mylotarg dosage: 10.8 MG OVER 2 HOURS. During the same period patient was treated with DAUNORUBICIN, CYTARABINE. Patient died on 12/12/2006.Mylotarg Side Effects Report #4957383-3
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Mar 15, 2006. Male patient, 37 years of age, weighting 226.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: catheter sepsis, cerebral haemorrhage, condition aggravated, hallucination, leukopenia, neutropenia, photophobia, staphylococcal sepsis, thrombocytopenia. Mylotarg dosage: 13.8 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, DAUNOMYCIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5762735-8
Mylotarg side effect was reported by a Physician from UNITED STATES on June 04, 2008. Female patient, 36 years of age, weighting 138.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, condition aggravated, pneumonia
, respiratory failure, thrombocytopenia. Mylotarg dosage: 9.6 MG. During the same period patient was treated with DAUNORUBICIN, CYTARABINE. Patient was hospitalized. Patient died on 05/25/2008.Mylotarg Side Effects Report #5055667-4
Mylotarg side effect was reported by a Physician from UNITED STATES on June 30, 2006. Female patient, 34 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cellulitis
, condition aggravated, escherichia bacteraemia, febrile neutropenia, pancytopenia, perirectal abscess. Mylotarg dosage: 4 MG/M^2 1X PER 1 DAY, INTRAVENOUS; SEE IMAGE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4766821-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 29, 2005. Female patient, 34 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cellulitis
, condition aggravated, escherichia bacteraemia, pancytopenia, perirectal abscess. Mylotarg dosage: 4 MG/M^2 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4948795-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 34 years of age, weighting 194.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain
, blast cells present, chills, condition aggravated, diarrhoea, dyspnoea, haematocrit decreased, haemoglobin decreased, hypotension. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5143396-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 27, 2006. Male patient, 31 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood potassium decreased, blood sodium decreased, condition aggravated, staphylococcal sepsis. Mylotarg dosage: A SINGEL 15 MG DOSE 99 MG/M^2) INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, ETOPOSIDE, OMEPRAZOLE, DIFLUCAN, CLOSTRIDIUM BUTYRICUM, MINOPEN, HABEKACIN, NEUPOGEN. Patient died.
Mylotarg Side Effects Report #4976448-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 03, 2006. Male patient, 31 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood potassium decreased, blood sodium decreased, condition aggravated, infusion related reaction, leukaemia recurrent, malignant neoplasm progression, staphylococcal sepsis. Mylotarg dosage: A SINGLE 15 MG DOSE (9 MG/M^2). During the same period patient was treated with CYTARABINE, ETOPOSIDE, OMEPRAZOLE, DIFLUCAN, CLOSTRIDIUM BUTYRICUM, MINOPEN, HABEKACIN, NEUPOGEN. Patient died.
Mylotarg Side Effects Report #5239591-X
Mylotarg side effect was reported by a Physician from JAPAN on Feb 08, 2007. Male patient, 30 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, obliterative bronchiolitis, sepsis
. Mylotarg dosage: 15 MG DAILY. Patient died on 01/31/2007.Mylotarg Side Effects Report #5159291-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 07, 2006. Male patient, 30 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, bladder disorder, bone marrow failure, catheter related complication, condition aggravated, cystitis haemorrhagic, depressed level of consciousness, gait disturbance. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with DIFLUCAN, AMLODIPINE BESYLATE, FAMOTIDINE, SULFAMETHOXAZOLE, PREDNISOLONE, LOSARTAN POTASSIUM, LASIX. Patient died.
Mylotarg Side Effects Report #5192184-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 12, 2006. Female patient, 29 years of age, was diagnosed with acute myeloid leukaemia, disease recurrence and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, c-reactive protein increased, condition aggravated, disease progression, herpes zoster, malaise, platelet count decreased, pleural effusion. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY; INTRAVENOUS DRIP;. During the same period patient was treated with ETOPOSIDE, VFEND, CEFTAZIDIME, AMIKACIN SULPHATE, MEROPEN. Patient recovered.
Mylotarg Side Effects Report #5256286-7
Mylotarg side effect was reported by a Physician from JAPAN on Feb 23, 2007. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cardiac failure, condition aggravated, neutrophil count decreased, sepsis
. Mylotarg dosage: unknown. During the same period patient was treated with VFEND, LASIX, DIAMOX, TIENAM. Patient died on 11/17/2006.Mylotarg Side Effects Report #5283730-1
Mylotarg side effect was reported by a Physician from JAPAN on Mar 23, 2007. Male patient, weighting 169.8 lb, was diagnosed with acute myeloid leukaemia, prophylaxis, insomnia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood fibrinogen increased, blood lactate dehydrogenase increased, blood pressure diastolic increased, c-reactive protein increased, condition aggravated, fibrin degradation products increased, nausea
. Mylotarg dosage: unknown. During the same period patient was treated with GASTER, PRORENAL, ACLARUBICIN HYDROCHLORIDE, MUCOSTA, ZOLPIDEM TARTRATE, CYTARABINE, ETODOLAC, BAKTAR. Patient recovered.Mylotarg Side Effects Report #5286578-7
Mylotarg side effect was reported by a Physician from JAPAN on Mar 27, 2007. Male patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood urea increased, c-reactive protein increased, condition aggravated, performance status decreased, pneumonia
, white blood cell count increased. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE, MEROPEN, AMIKACIN, GASTER, PREDONINE, DIFLUCAN, BAKTAR. Patient died on 02/16/2007.Mylotarg Side Effects Report #5295739-2
Mylotarg side effect was reported by a Physician from JAPAN on Apr 04, 2007. Female patient, weighting 110.2 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood pressure decreased, condition aggravated, small intestinal haemorrhage. Mylotarg dosage: unknown. During the same period patient was treated with OMEPRAZOLE, MAXIPIME, CARBENIN, MICAFUNGIN. Patient died on 03/20/2007.
Mylotarg Side Effects Report #5299514-4
Mylotarg side effect was reported by a Physician from JAPAN on Apr 12, 2007. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cardiac failure, condition aggravated, neutrophil count decreased, sepsis
. Mylotarg dosage: unknown. During the same period patient was treated with VFEND, LASIX, DIAMOX. Patient died on 11/17/2006.Mylotarg Side Effects Report #5316413-X
Mylotarg side effect was reported by a Physician from JAPAN on Apr 26, 2007. Male patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood urea increased, c-reactive protein increased, condition aggravated, performance status decreased, pneumonia
, white blood cell count increased. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE, MEROPEN, AMIKACIN, GASTER, PREDONINE, DIFLUCAN, BAKTAR. Patient recovered.Mylotarg Side Effects Report #5334244-1
Mylotarg side effect was reported by a Physician from JAPAN on May 17, 2007. Female patient, weighting 88.18 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, hepatitis
, neutrophil count decreased. Mylotarg dosage: unknown. During the same period patient was treated with DIFLUCAN, BAKTAR, LEVOFLOXACIN. Patient recovered.Mylotarg Side Effects Report #5374514-4
Mylotarg side effect was reported by a Physician from JAPAN on June 21, 2007. Female patient, weighting 88.18 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cells present, chills, condition aggravated, febrile neutropenia, hepatitis
, neutrophil count decreased, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with DIFLUCAN, BAKTAR, LEVOFLOXACIN. Patient recovered.Mylotarg Side Effects Report #5395435-7
Mylotarg side effect was reported by a Physician from JAPAN on July 17, 2007. Male patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood urea increased, cerebral haemorrhage, condition aggravated, disseminated intravascular coagulation, febrile neutropenia, hypernatraemia, pneumonia
, renal impairment. Mylotarg dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, ROXATIDINE ACETATE, GLUCOSEECTION, DIFLUCAN, VITAMEDIN, SOLDEM, STRONG NEO MINOPHAGEN C. Patient was hospitalized. Patient died on 02/23/2007.Mylotarg Side Effects Report #5451515-9
Mylotarg side effect was reported by a Physician from JAPAN on Sept 04, 2007. Male patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood urea increased, cerebral haemorrhage, condition aggravated, disseminated intravascular coagulation, febrile neutropenia, hypernatraemia, pneumonia
, renal impairment. Mylotarg dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, ROXATIDINE ACETATE, GLUCOSEECTION, DIFLUCAN, VITAMEDIN, SOLDEM, STRONG NEO MINOPHAGEN C. Patient was hospitalized. Patient died on 02/23/2007.Mylotarg Side Effects Report #5490781-0
Mylotarg side effect was reported by a Physician from JAPAN on Oct 11, 2007. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, neutrophil count decreased, pneumonia
, thrombocytopenia. Mylotarg dosage: unknown. During the same period patient was treated with BAKTAR, SIGMART, FRANDOL, DILTIAZEM, PURSENNID, FAMOTIDINE, DIFLUCAN. Patient died on 03/10/2007.Mylotarg Side Effects Report #5535979-8
Mylotarg side effect was reported by a Physician from JAPAN on Dec 03, 2007. Male patient, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, condition aggravated, febrile neutropenia, leukaemia, multi-organ failure. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 07/04/2007.
Mylotarg Side Effects Report #5781375-8
Mylotarg side effect was reported by a Physician from JAPAN on June 17, 2008. Male patient, weighting 147.7 lb, was diagnosed with acute myeloid leukaemia, endotracheal intubation, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, febrile neutropenia, pulmonary alveolar haemorrhage, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with ADONA, ROPION, TRANSAMIN, MIDAZOLAM, PRODIF, HYDROCORTONE, TARGOCID. Patient recovered.